Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.03
+0.09 (1.72%)
Oct 3, 2024, 12:25 PM EDT - Market open
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $186.85 million as of October 3, 2024. Its market cap has decreased by -51.47% in one year.
Market Cap
186.85M
Enterprise Value
123.12M
1-Year Change
-51.47%
Ranking
Category
Stock Price
$5.01
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $183.30M to $186.85M, an increase of 1.94%. That is a compound annual growth rate of 0.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2024 | 186.90M | -42.72% |
| Dec 29, 2023 | 326.30M | 6.74% |
| Dec 30, 2022 | 305.70M | 48.33% |
| Dec 31, 2021 | 206.10M | -21.34% |
| Dec 31, 2020 | 262.00M | 42.94% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Benitec Biopharma | 193.75M |
| CVRx, Inc. | 189.32M |
| Vaxart | 189.21M |
| Akso Health Group | 189.19M |
| Greenwich LifeSciences | 188.23M |
| Atai Life Sciences | 187.93M |
| Atossa Therapeutics | 187.38M |
| MediWound | 185.31M |